DONGSUNG PHARMACEUTICAL CO.,LTD Logo

DONGSUNG PHARMACEUTICAL CO.,LTD

A Korean firm making pharmaceuticals, cosmetics, and popular hair care products for over 60 years.

002210 | KO

Overview

Corporate Details

ISIN(s):
KR7002210003
LEI:
Country:
South Korea
Address:
서울특별시 도봉구 도봉로 683 (방학동) 동성빌딩, 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Dongsung Pharmaceutical Co., Ltd. is a Korean company engaged in the manufacture and distribution of pharmaceuticals, cosmetics, and hair care products, with a history of over 60 years. The company's portfolio includes both prescription (ETC) and over-the-counter (OTC) medicines, with notable products like the gastrointestinal drug 'Jeongro-hwan'. In the consumer sector, Dongsung is well-known for its 'Seven-Ait' hair dye brand and a diverse line of cosmetics. The company focuses on developing nature-friendly products and is also active in research areas such as photodynamic therapy.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-15 00:00
Post-Annual General Meeting Information
임시주주총회결과
Korean 19.0 KB
2025-09-10 00:00
Legal Proceedings Report
소송등의제기ㆍ신청(경영권분쟁소송)
Korean 9.7 KB
2025-08-26 00:00
Legal Proceedings Report
소송등의판결ㆍ결정
Korean 6.7 KB
2025-08-25 00:00
Legal Proceedings Report
소송등의판결ㆍ결정
Korean 5.4 KB
2025-08-19 00:00
Proxy Solicitation & Information Statement
[기재정정]의결권대리행사권유참고서류
Korean 109.6 KB
2025-08-18 00:00
Legal Proceedings Report
소송등의제기ㆍ신청(경영권분쟁소송)
Korean 6.8 KB
2025-08-14 00:00
Major Shareholding Notification
[기재정정]주식등의대량보유상황보고서(일반)
Korean 91.0 KB
2025-08-14 00:00
Major Shareholding Notification
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Korean 27.7 KB
2025-08-14 00:00
Audit Report / Information
반기검토의견부적정또는의견거절
Korean 6.4 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 903.0 KB
2025-08-14 00:00
Regulatory News Service
상장적격성실질심사관련주요개선계획(자율공시)
Korean 3.9 KB
2025-08-13 00:00
Proxy Solicitation & Information Statement
[기재정정]의결권대리행사권유참고서류
Korean 79.7 KB
2025-08-13 00:00
Delisting Announcement
기타시장안내 (개선기간 부여 결정)
Korean 6.0 KB
2025-08-11 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의
Korean 29.4 KB
2025-08-11 00:00
Proxy Solicitation & Information Statement
[기재정정]의결권대리행사권유참고서류
Korean 74.3 KB

Automate Your Workflow. Get a real-time feed of all DONGSUNG PHARMACEUTICAL CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DONGSUNG PHARMACEUTICAL CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DONGSUNG PHARMACEUTICAL CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

curacle co., ltd. Logo
Developing drugs for intractable diseases like diabetes caused by vascular damage and aging.
South Korea
365270
Curanex Pharmaceuticals Inc Logo
Developing botanical drugs for inflammatory diseases, diabetes, and COVID-19.
United States of America
CURX
Curevac Logo
Pioneering mRNA technology to create vaccines and therapies for infectious diseases, cancer, and more.
Germany
CVAC
CureVac N.V. Logo
Pioneering mRNA technology for prophylactic vaccines and novel cancer immunotherapies.
United States of America
CVAC
CURIS INC Logo
Biotech developing innovative cancer therapeutics for hematologic malignancies.
United States of America
CRIS
Curocell Inc. Logo
Biotech developing enhanced CAR-T therapies for cancer using its OVIS™ platform.
South Korea
372320
CYBIN INC. Logo
A clinical-stage firm engineering novel psychedelic drugs for depression and anxiety.
United States of America
CYBN
Cyclerion Therapeutics, Inc. Logo
Developing personalized therapy for TRD with a biofeedback device and anesthetics.
United States of America
CYCN
CYTOKINETICS INC Logo
Late-stage biopharma developing muscle-modulating drugs for heart and neuromuscular diseases.
United States of America
CYTK

Talk to a Data Expert

Have a question? We'll get back to you promptly.